| INSMED INC. DL-,01 |
| USA |
| Gesundheit |
| US4576693075 / A1JJA3 |
| IM8N (Frankfurt) / INSM (NASDAQ) |
| FRA:IM8N, ETR:IM8N, IM8N:GR, NASDAQ:INSM |
| - |
| https://insmed.com/ |
|
Insmed Inc. is a global biopharmaceutical company focused on developing and commercializing therapies for patients with serious and rare diseases. The company concentrates its activities across three key therapeutic areas: respiratory, immunology and..
>Volltext.. |
| 18505.77 Mio. EUR |
| 18095.38 Mio. EUR |
| 710.74 Mio. EUR |
| -820.58 Mio. EUR |
| -1026.57 Mio. EUR |
| -4.98 EUR |
| 649.05 Mio. EUR |
| 504.88 Mio. EUR |
| -776.73 Mio. EUR |
| 3.39 |
| 101.4% |
| -9.39% |
| - |
| - |
| - |
| 2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 3.240.875 Euro. |
| INSMED |
| 06.08.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|